Regulation of β cleavage of amyloid precursor protein

Neuroscience Bulletin

Volumn 26, Issue 5, 2010, Pages 417-427

  Wang, Jun Feng ^a   Lu, Rui ^a   Wang, Yi Zheng ^a  

^a Chinese Academy of Sciences   (China)

Author keywords

secretase; Alzheimer's disease; Amyloid peptide; Amyloid precursor protein

Indexed keywords

ADAM10 ENDOPEPTIDASE; ADAPTOR PROTEIN; ALPHA SECRETASE; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; BETA SECRETASE 1; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; G PROTEIN COUPLED RECEPTOR; INITIATION FACTOR 2; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; METAL ION; TRANSCRIPTION FACTOR NFAT;

ALZHEIMER DISEASE; AMYLOIDOSIS; CYTOPLASM; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; ENZYME ACTIVITY; GLYCOSYLATION; HUMAN; IMMUNOHISTOCHEMISTRY; LIPID RAFT; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; REVIEW; SIGNAL TRANSDUCTION; TRANS GOLGI NETWORK; TRANSCRIPTION REGULATION;

ALZHEIMER DISEASE; AMYLOID; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; HUMANS; SIGNAL TRANSDUCTION;

EID: 78650215509     PISSN: 16737067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12264-010-0515-1     Document Type: Review

References (81)

1. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM. Forecasting the global burden of Alzheimer's disease. Alzheimers Dement 2007, 3:186-191.
2. Selkoe DJ. Alzheimer disease: mechanistic understanding predicts novel therapies. Ann Intern Med 2004, 140:627-638.
3. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, et al. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 1991, 30:572-580.
4. Selkoe DJ. Alzheimer's disease is a synaptic failure. Science 2002, 298:789-791.
5. Mudher A, Lovestone S. Alzheimer's disease-do tauists and baptists finally shake hands? Trends Neurosci 2002, 25:22-26.
6. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
7. Hardy J. Has the amyloid cascade hypothesis for Alzheimer's disease been proved? Curr Alzheimer Res 2006, 3:71-73.
8. Lesne S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, et al. A specific amyloid-βprotein assembly in the brain impairs memory. Nature 2006, 440:352-357.
9. Dahlgren KN, Manelli AM, Stine WB Jr, Baker LK, Krafft GA, LaDu MJ. Oligomeric and fibrillar species of amyloid-P peptides differentially affect neuronal viability. J Biol Chem 2002, 277:32046-32053.
10. Leissring MA, Farris W, Chang AY, Walsh DM, Wu X, Sun X, et al. Enhanced proteolysis of β-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Neuron 2003, 40:1087-1093.
11. Ohno M, Cole SL, Yasvoina M, Zhao J, Citron M, Berry R, et al. BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP/PS1 transgenic mice. Neurobiol Dis 2007, 26:134-145.
12. Gandy S. The role of cerebral amyloid beta accumulation in common forms of Alzheimer disease. J Clin Invest 2005, 115:1121-1129.
13. Roychaudhuri R, Yang M, Hoshi MM, Teplow DB. Amyloid β-protein assembly and Alzheimer disease. J Biol Chem 2009, 284:4749-4753.
14. Thinakaran G, Koo EH. Amyloid precursor protein trafficking, processing, and function. J Biol Chem 2008, 283:29615-29619.
15. Mills J, Reiner PB. Regulation of amyloid precursor protein cleavage. J Neurochem 1999, 72:443-460.
16. Lee MS, Kao SC, Lemere CA, Xia W, Tseng HC, Zhou Y, et al. APP processing is regulated by cytoplasmic phosphorylation. J Cell Biol 2003, 163:83-95.
17. Oishi M, Nairn AC, Czernik AJ, Lim GS, Isohara T, Gandy SE, et al. The cytoplasmic domain of Alzheimer's amyloid precursor protein is phosphorylated at Thr654, Ser655, and Thr668 in adult rat brain and cultured cells. Mol Med 1997, 3:111-123.
18. da Cruz e Silva EF, da Cruz e Silva OA. Protein phosphorylation and APP metabolism. Neurochem Res 2003, 28:1553-1561.
19. Adlard PA, Cherny RA, Finkelstein DI, Gautier E, Robb E, Cortes M, et al. Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Aβ. Neuron 2008, 59:43-55.
20. Suzuki T, Nakaya T. Regulation of amyloid beta-protein precursor by phosphorylation and protein interactions. J Biol Chem 2008, 283:29633-29637.
21. Ando K, Iijima KL, Elliott JI, Kirino Y, Suzuki T. Phosphorylation- dependent regulation of the interaction of amyloid precursor protein with Fe65 affects the production of P-amyloid. J Biol Chem 2001, 276:40353-40361.
22. Sabo SL, Lanier LM, Ikin AF, Khorkova O, Sahasrabudhe S, Greengard P, et al. Regulation of P-amyloid secretion by FE65, an amyloid protein precursor-binding protein. J Biol Chem 1999, 274:7952-7957.
23. Santiard-Baron D, Langui D, Delehedde M, Delatour B, Schombert B, Touchet N, et al. Expression of human FE65 in amyloid precursor protein transgenic mice is associated with a reduction in β-amyloid load. J Neurochem 2005, 93:330-338.
24. Pietrzik CU, Yoon IS, Jaeger S, Busse T, Weggen S, Koo EH. FE65 constitutes the functional link between the low-density lipoprotein receptor-related protein and the amyloid precursor protein. J Neurosci 2004, 24:4259-4265.
25. Miller CC, McLoughlin DM, Lau KF, Tennant ME, Rogelj B. The X11 proteins, Abeta production and Alzheimer's disease. Trends Neurosci 2006, 29:280-285.
26. Sastre M, Turner RS, Levy E. X11 interaction with beta-amyloid precursor protein modulates its cellular stabilization and reduces amyloid P-protein secretion. J Biol Chem 1998, 273:22351-22357.
27. Lee JH, Lau KF, Perkinton MS, Standen CL, Shemilt SJ, Mercken L, et al. The neuronal adaptor protein X11α reduces Aβ levels in the brains of Alzheimer's APPswe Tg2576 transgenic mice. J Biol Chem 2003, 278:47025-47029.
28. Lee JH, Lau KF, Perkinton MS, Standen CL, Rogelj B, Falinska A, et al. The neuronal adaptor protein X11p reduces amyloid β-protein levels and amyloid plaque formation in the brains of transgenic mice. J Biol Chem 2004, 279:49099-49104.
29. Parisiadou L, Efthimiopoulos S. Expression of mDab1 promotes the stability and processing of amyloid precursor protein and this effect is counteracted by X11alpha. Neurobiol Aging 2007, 28:377-388.
30. Lau KF, McLoughlin DM, Standen CL, Irving NG, Miller CC. Fe65 and X11p co-localize with and compete for binding to the amyloid precursor protein. Neuroreport 2000, 11:3607-3610.
31. Kwon OY, Hwang, K, Kim, JA, Kim, K, Kwon, IC, Song, HK, et al. Dab1 binds to Fe65 and diminishes the effect of Fe65 or LRP1 on APP processing. J Cell Biochem 2010. [Epub ahead of print].
32. Lee JH, Barral S, Reitz C. The neuronal sortilin-related receptor gene SORL1 and late-onset Alzheimer's disease. Curr Neurol Neurosci Rep 2008, 8:384-391.
33. Small SA, Gandy S. Sorting through the cell biology of Alzheimer's disease: intracellular pathways to pathogenesis. Neuron 2006, 52:15-31.
34. Spoelgen R, von Arnim CA, Thomas AV, Peltan ID, Koker M, Deng A, et al. Interaction of the cytosolic domains of sorLA/LR11 with the amyloid precursor protein (APP) and P-secretase β-site APP-cleaving enzyme. J Neurosci 2006, 26:418-428.
35. Andersen OM, Reiche J, Schmidt V, Gotthardt M, Spoelgen R, Behlke J, et al. Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein. Proc Natl Acad Sci U S A 2005, 102:13461-13466.
36. Rogaeva E, Meng Y, Lee JH, Gu Y, Kawarai T, Zou F, et al. The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet 2007, 39:168-177.
37. Rohe, M, Synowitz, M, Glass, R, Paul, SM, Nykjaer, A & Willnow, TE Brain-derived neurotrophic factor reduces amyloidogenic processing through control of SORLA gene expression. J Neurosci 2009, 29:15472.-15478
38. Buckner RL, Snyder AZ, Shannon BJ, LaRossa G, Sachs R, Fotenos AF, et al. Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. J Neurosci 2005, 25:7709-7717.
39. Mackenzie IR, Miller LA. Senile plaques in temporal lobe epilepsy. Acta Neuropathol 1994, 87:504-510.
40. Jankowsky JL, Xu G, Fromholt D, Gonzales V, Borchelt DR. Environmental enrichment exacerbates amyloid plaque formation in a transgenic mouse model of Alzheimer disease. J Neuropathol Exp Neurol 2003, 62:1220-1227.
41. Kamenetz F, Tomita T, Hsieh H, Seabrook G, Borchelt D, Iwatsubo T, et al. APP processing and synaptic function. Neuron 2003, 37:925-937.
42. Cirrito JR, Kang JE, Lee J, Stewart FR, Verges DK, Silverio LM, et al. Endocytosis is required for synaptic activity-dependent release of amyloid-beta in vivo. Neuron 2008, 58:42-51.
43. Bush AI. Drug development based on the metals hypothesis of Alzheimer's disease. J Alzheimers Dis 2008, 15:223-240.
44. Lannfelt L, Blennow K, Zetterberg H, Batsman S, Ames D, Harrison J, et al. Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial. Lancet Neurol 2008, 7:779-786.
45. Relkin NR. Testing the mettle of PBT2 for Alzheimer's disease. Lancet Neurol 2008, 7:762-763.
46. Yu J, Sun M, Chen Z, Lu J, Liu Y, Zhou L, et al. Magnesium modulates amyloid-β protein precursor trafficking and processing. J Alzheimers Dis 2010, 20:1091-1106.
47. Sinha S, Anderson JP, Barbour R, Basi GS, Caccavello R, Davis D, et al. Purification and cloning of amyloid precursor protein β-secretase from human brain. Nature 1999, 402:537-540.
48. Hussain I, Powell D, Howlett DR, Tew DG, Meek TD, Chapman C, et al. Identification of a novel aspartic protease (Asp 2) as β-secretase. Mol Cell Neurosci 1999, 14:419-427.
49. Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, et al. P-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 1999, 286:735-741.
50. Yan R, Bienkowski MJ, Shuck ME, Miao H, Tory MC, Pauley AM, et al. Membrane-anchored aspartyl protease with Alzheimer's disease P-secretase activity. Nature 1999, 402:533-537.
51. Lin X, Koelsch G, Wu S, Downs D, Dashti A, Tang J. Human aspartic protease memapsin 2 cleaves the β-secretase site of β-amyloid precursor protein. Proc Natl Acad Sci U S A 2000, 97:1456-1460.
52. Cai H, Wang Y, McCarthy D, Wen H, Borchelt DR, Price DL, et al. BACE1 is the major β-secretase for generation of Aβ peptides by neurons. Nat Neurosci 2001, 4:233-234.
53. Yan R, Munzner JB, Shuck ME, Bienkowski MJ. BACE2 functions as an alternative a-secretase in cells. J Biol Chem 2001, 276:34019-34027.
54. Luo Y, Bolon B, Kahn S, Bennett BD, Babu-Khan S, Denis P, et al. Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished β-amyloid generation. Nat Neurosci 2001, 4:231-232.
55. Roberds SL, Anderson J, Basi G, Bienkowski MJ, Branstetter DG, Chen KS, et al. BACE knockout mice are healthy despite lacking the primary β-secretase activity in brain: implications for Alzheimer's disease therapeutics. Hum Mol Genet 2001, 10:1317-1324.
56. Fukumoto H, Rosene DL, Moss MB, Raju S, Hyman BT, Irizarry MC. β-Secretase activity increases with aging in human, monkey, and mouse brain. Am J Pathol 2004, 164:719-725.
57. Yang LB, Lindholm K, Yan R, Citron M, Xia W, Yang XL, et al. Elevated β-secretase expression and enzymatic activity detected in sporadic Alzheimer disease. Nat Med 2003, 9:3-4.
58. Cole SL, Vassar R. The Alzheimer's disease β-secretase enzyme, BACE1. Mol Neurodegener 2007, 2:22..
59. Zhang X, Zhou K, Wang R, Cui J, Lipton SA, Liao FF, et al. Hypoxia-inducible factor 1alpha (HIF-1α)-mediated hypoxia increases BACE1 expression and β-amyloid generation. J Biol Chem 2007, 282:10873-10880.
60. Tamagno E, Guglielmotto M, Aragno M, Borghi R, Autelli R, Giliberto L, et al. Oxidative stress activates a positive feedback between the gamma-and β-secretase cleavages of the P-amyloid precursor protein. J Neurochem 2008, 104:683-695.
61. Shen C, Chen Y, Liu H, Zhang K, Zhang T, Lin A, et al. Hydrogen peroxide promotes Aβ production through JNK-dependent activation of gamma-secretase. J Biol Chem 2008, 283:17721-17730.
62. Cho HJ, Jin SM, Youn HD, Huh K, Mook-Jung I. Disrupted intracellular calcium regulates BACE1 gene expression via nuclear factor of activated T cells 1 (NFAT 1) signaling. Aging Cell 2008, 7:137-147.
63. Buggia-Prevot V, Sevalle J, Rossner S, Checler F. NFKB-dependent control of BACE1 promoter transactivation by Aβ42. J Biol Chem 2008, 283:10037-10047.
64. O'Connor T, Sadleir KR, Maus E, Velliquette RA, Zhao J, Cole SL, et al. Phosphorylation of the translation initiation factor eIF2a increases BACE1 levels and promotes amyloidogenesis. Neuron 2008, 60:988-1009.
65. Velliquette RA, O'Connor T, Vassar R. Energy inhibition elevates p-secretase levels and activity and is potentially amyloidogenic in APP transgenic mice: possible early events in Alzheimer's disease pathogenesis. J Neurosci 2005, 25:10874-10883.
66. Guo Q, Fu W, Xie J, Luo H, Sells SF, Geddes JW, et al. Par-4 is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer disease. Nat Med 1998, 4:957-962.
67. Xie J, Guo Q. PAR-4 is involved in regulation of P-secretase cleavage of the Alzheimer amyloid precursor protein. J Biol Chem 2005, 280:13824-13832.
68. He W, Lu Y, Qahwash I, Hu XY, Chang A, Yan R. Reticulon family members modulate BACE1 activity and amyloid-β peptide generation. Nat Med 2004, 10:959-965.
69. Murayama KS, Kametani F, Saito S, Kume H, Akiyama H, Araki W. Reticulons RTN3 and RTN4-B/C interact with BACE1 and inhibit its ability to produce amyloid β-protein. Eur J Neurosci 2006, 24:1237-1244.
70. Scholefield Z, Yates EA, Wayne G, Amour A, McDowell W, Turnbull JE. Heparan sulfate regulates amyloid precursor protein processing by BACE1, the Alzheimer's β-secretase. J Cell Biol 2003, 163:97-107.
71. He X, Li F, Chang WP, Tang J. GGA proteins mediate the recycling pathway of memapsin 2 (BACE). J Biol Chem 2005, 280:11696-11703.
72. Tesco G, Koh YH, Kang EL, Cameron AN, Das S, Sena-Esteves M, et al. Depletion of GGA3 stabilizes BACE and enhances β-secretase activity. Neuron 2007, 54:721-737.
73. Okada H, Zhang W, Peterhoff C, Hwang JC, Nixon RA, Ryu SH, et al. Proteomic identification of sorting nexin 6 as a negative regulator of BACE1-mediated APP processing. FASEB J 2010, 24(8):2783-2794.
74. Teng L, Zhao J, Wang F, Ma L, Pei G. A GPCR/secretase complex regulates β-and γ-secretase specificity for Aβ production and contributes to AD pathogenesis. Cell Res 2010, 20:138-153.
75. Ehehalt R, Keller P, Haass C, Thiele C, Simons K. Amyloidogenic processing of the Alzheimer P-amyloid precursor protein depends on lipid rafts. J Cell Biol 2003, 160:113-123.
76. Sparks DL, Scheff SW, Hunsaker JC 3rd, Liu H, Landers T, Gross DR. Induction of Alzheimer-like ß-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol. Exp Neurol 1994, 126:88-94.
77. Fassbender K, Simons M, Bergmann C, Stroick M, Lutjohann D, Keller P, et al. Simvastatin strongly reduces levels of Alzheimer's disease P-amyloid peptides Aβ 42 and Aβ 40 in vitro and in vivo. Proc Natl Acad Sci U S A 2001, 98:5856-5861.
78. Yankner BA, Dawes LR, Fisher S, Villa-Komaroff L, Oster-Granite ML, Neve RL. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science 1989, 245:417-420.
79. Nalivaeva NN, Fisk LR, Belyaev ND, Turner AJ. Amyloid-degrading enzymes as therapeutic targets in Alzheimer's disease. Curr Alzheimer Res 2008, 5:212-224.
80. Risner ME, Saunders AM, Altman JF, Ormandy GC, Craft S, Foley IM, et al. Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease. Pharmacogenomics J 2006, 6:246-254.
81. Holmes C, Boche D, Wilkinson D, Yadegarfar G, Hopkins V, Bayer A, et al. Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial. Lancet 2008, 372:216-223.